Maravai LifeSciences Announces Registration and Webcast Information for Upcoming R&D Day, to be Held on January 28, 2022
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) has announced its first Investor R&D Day, set for January 28, 2022, from 9:00 a.m. to 11:30 a.m. Pacific Time.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) has announced its first Investor R&D Day, set for January 28, 2022, from 9:00 a.m. to 11:30 a.m. Pacific Time. This virtual event aims to provide insights into its life science reagents and services, primarily for biotechnology and pharmaceutical innovations. Attendees can pre-register for the event, and a playback will be available afterward. Maravai continues to be a leader in providing products for drug therapies, diagnostics, and novel vaccines.
Positive
- First Investor R&D Day scheduled for January 28, 2022, promoting transparency.
- Opportunity for investors to learn about Maravai's advancements in life sciences.
Negative
- None.
Details
News Market Reaction – MRVI
The recorded move for MRVI in the trading session of this news was -3.89%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced details for its first ever Investor R&D Day.
The event will be held virtually on January 28, 2022, beginning at 9:00 a.m. Pacific Time. The event should conclude at approximately 11:30 a.m. Pacific Time.
Attendees are encouraged to pre-register for the webcast by following this link and completing the registration form. A link to the live webcast and related materials will also be available in the Investor Relations section of Maravai website, https://investors.maravai.com/news-events/events-presentations. A replay will be available after the conclusion of the event.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologic safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies.
For more information about Maravai LifeSciences, visit www.maravai.com.
Contact Information:
Media Contact: Sara Michelmore
MacDougall Advisors
+1 781-235-3060
maravai@macdougall.bio
Investor Contact: Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
ir@maravai.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.